GSK will contribute 98.8kg of albuterol.

True

Evidence from credible sources supports the statement as accurate. Learn more in Methodology.

Interesting: 0/0 • Support: 0/0Log in to vote

funding

Contribution delivered as described.

Source summary

President Donald J. Trump announced nine agreements with major pharmaceutical companies to align U.S. drug prices with the lowest prices paid in other developed nations (MFN pricing). The deals provide State Medicaid programs access to MFN prices, require companies to offer steep discounts through the administrations TrumpRx channel, and include commitments to repatriate foreign revenue and invest at least $150 billion in U.S. manufacturing. Companies will also donate active pharmaceutical ingredients to a Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The announcement follows prior executive actions and an international agreement with the U.K. to raise net prices there.

View original article →

The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), the active ingredient in many inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD). (whitehouse.gov) This contribution is part of a broader agreement between GSK and the U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans. (us.gsk.com)

Sources

Timeline

Update · Dec 21, 2025, 09:00 AMTrue
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), the active ingredient in many inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD). (whitehouse.gov) This contribution is part of a broader agreement between GSK and the U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans. (us.gsk.com)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Update · Dec 21, 2025, 07:49 AMTrue
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). Albuterol is the active ingredient in rescue inhalers for asthma patients. (whitehouse.gov) This contribution is part of a broader agreement between GSK and the U.S. government to lower drug prices and expand access to respiratory medicines. (us.gsk.com)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Update · Dec 21, 2025, 07:04 AMTrue
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). Albuterol is the active ingredient in rescue inhalers for asthma patients. (whitehouse.gov) This contribution is part of a broader agreement between GSK and the U.S. government to lower drug prices and expand access to respiratory medicines. (us.gsk.com)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Update · Dec 21, 2025, 05:55 AMUnverifiable
The statement that GSK will contribute 98.8 kg of albuterol is not directly supported by publicly available information. While GSK has entered into an agreement with the U.S. government to lower drug prices and expand access to respiratory medicines, including albuterol, specific details about the quantity of albuterol to be contributed are not disclosed in the available sources. (us.gsk.com) Therefore, the exact amount of albuterol GSK will provide remains unverified.
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Update · Dec 21, 2025, 05:07 AMTrue
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). Albuterol is the active ingredient in many inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD). (whitehouse.gov) This contribution is part of a broader agreement between GSK and the U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans. (us.gsk.com)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Update · Dec 21, 2025, 04:25 AMTrue
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), the active ingredient in many inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD). (whitehouse.gov) This contribution is part of a broader agreement with the U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans. (us.gsk.com)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Update · Dec 21, 2025, 02:56 AMUnverifiable
The statement that GSK will contribute 98.8 kg of albuterol, the active ingredient in a common rescue inhaler for people with asthma, cannot be verified with the available information. While GSK has entered into an agreement with the U.S. government to lower drug prices and expand access to respiratory medicines, specific details about the quantity of albuterol to be provided are not disclosed in the available sources. (us.gsk.com)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
Update · Dec 20, 2025, 11:49 PMTrue
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). Albuterol is the active ingredient in common rescue inhalers for asthma patients. (whitehouse.gov) This contribution is part of a broader initiative where pharmaceutical companies are donating active pharmaceutical ingredients to bolster the United States' preparedness for emergencies. (whitehouse.gov)
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
Update · Dec 20, 2025, 08:46 AMcomplete
The White House announced on December 19, 2025, that GSK will contribute 98.8 kilograms of albuterol to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR), aiming to bolster the U.S. supply of critical medications. (whitehouse.gov) This contribution is part of a broader agreement between GSK and the U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans. (us.gsk.com) Therefore, the statement that GSK will contribute 98.8 kg of albuterol is accurate.
- https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/
- https://us.gsk.com/en-us/media/press-releases/gsk-enters-agreement-with-us-government-to-lower-drug-prices-and-expand-access-to-respiratory-medicines-for-millions-of-americans/
Original article · Dec 19, 2025
View article

Comments

Only logged-in users can comment.

Loading…